Non Motors Aspects in De Novo Parkinson's Disease: Clinical and Physiopathological Description; Dopamine Agonist Treatment Effects.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms Honeymoon
- 25 Oct 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.
- 25 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 23 Jun 2016 New trial record